4.7 Article

Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13

Related references

Note: Only part of the references are listed.
Article Hematology

Pegylated arginase I: a potential therapeutic approach in T-ALL

Claudia P. Hernandez et al.

BLOOD (2010)

Article Oncology

Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice

Fuminori Abe et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)

Article Multidisciplinary Sciences

G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models

Farbod Shojaei et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Immunology

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

Je-In Youn et al.

JOURNAL OF IMMUNOLOGY (2008)

Review Medicine, Research & Experimental

Indoleamine 2,3-dioxygenase and tumor-induced tolerance

David H. Munn et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Article Hematology

L-arginine availability regulates T-lymphocyte cell-cycle progression

Paulo C. Rodriguez et al.

BLOOD (2007)

Article Medicine, Research & Experimental

Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells

Giovanna Gallina et al.

JOURNAL OF CLINICAL INVESTIGATION (2006)

Review Immunology

Regulation of immune responses by L- arginine metabolism

V Bronte et al.

NATURE REVIEWS IMMUNOLOGY (2005)

Article Biochemistry & Molecular Biology

Regulation of T cell receptor CD3 chain expression by L-arginine

PC Rodriguez et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)